The question of what’s behind the spate of vaping-related pulmonary diseases in the U.S. and Canada is vexing broad swaths of the cannabis industry. With vaping products rising in popularity and sales, there’s reason to be in a defensive mode; many of the public statements about these diseases point to problems in the illicit cannabis market or in the illicit e-cigarette market, but licensed cannabis businesses are embracing a cautious attitude of open communication about their products.
The illicit cannabis market has grown more sophisticated with the growing awareness of vaping technology and consumer choice. That gap that forms, then, is a lack of education about what constitutes a safe vaping product in a licensed cannabis market. That’s where business owners can approach this issue and draw out some transparency from the supply chain.
Ben Bodamer, an attorney in Dickinson Wright’s cannabis practice group, says that the opportunity is here to get out in front of the amorphous and uncertain public reaction to what’s become a mainstream national news story. While many cannabis brands are issuing statements about the safety of their products, there’s a more important structural and legal approach that needs to be considered.
In the meantime, it’s worth watching how federal and state regulators handle this story.
“This isn’t really just a story about one industry,” Bodamer says. “One question is: What is the intersection between the regulatory authority of the FDA and the federally non-compliant [but] state-compliant health-related cannabis business that is legal in 33 states? I consider we saw a small preview of that with what occurred with CBD final fall, exactly where the FDA commissioner sought to regulate CBD as a meals ingredient, in spite of the truth that it was technically federally non-compliant, so shouldn’t have been made use of as something from a federal viewpoint.
“You’ve observed what’s occurred,” he continues, “where there’s full confusion and a patchwork method to regulation. I consider a equivalent danger is totally doable in the context of vaping, specifically if there’s not meaningful distinction among the challenge of this illness and its origins and the hugely regulated, state-compliant cannabis marketplaces.”
“That query of provide chain danger and solution liability is 1 that I consider is pretty a lot on people’s minds. »
– Ben Bodamer, Dickinson Wright
Though a lot has been produced about constituents like Vitamin E acetate identified in illicit-industry cannabis vape merchandise, the basic public has raised suspicions about vaping additional broadly. Every thing beneath the sun has been rolled into this query about the security of vaping devices—including state-legal and tested cannabis merchandise, illicit-industry vapes, flavored e-cigarettes and so on. Licensed cannabis firms would do nicely to evaluate their personal standing in the industry and speak straight to their customer base.
Currently, President Trump has pushed the FDA to crack down on flavored e-cigarettes and eliminate them from shelves in the U.S. As Bodamer points out, there’s cause to look at a equivalent federal overreach into the state-legal cannabis space. No matter if something substantial will occur at the federal level remains unclear political momentum is moving toward issues like banking reform or some semblance of states’ rights legalization, but nothing at all is particular. Cannabis small business owners have a lot to have a tendency to without having predicting the climate in Washington, D.C.
“That query of provide chain danger and solution liability is 1 that I consider is pretty a lot on people’s minds,” he says, “and our assistance to clientele has been: You must have currently been performing a host of issues, combined with greatest practices in your whole provide chain, which includes complying with GMP practices, regardless of the truth that they’re not necessary by person states.”
It is the sort of point enshrined in environmental well being and security tenets of the 2013 Cole Memo. Although the federal document has been rescinded, the spirit of the memorandum has persisted as a guidepost for state-licensed cannabis marketplace etiquette.
Right here, Bodamer and fellow Dickinson Wright lawyer Scot Crow give a handful of strategies to consider about the glaring challenge of provide chain danger management.
Know Your Indemnification Provisions
“This business is hugely complicated,” Crow says, “and it is pretty effortless to uncover your self on the edge of a sword unintentionally simply because no 1 paid focus to these provisions in the agreement simply because everyone’s excited to the deal.”
An indemnification provision is otherwise identified as a hold-harmless provision. The legal language outlines who will spend for what when a conflict arises. Business enterprise executives must spend close focus to any mention of indemnification in distinct scenarios. Unknown and unforeseen situations can materialize in a maturing business, and the spate of vaping-connected lung illnesses is a terrific instance.
“The additional vital point is if I’m a dispensary, or retail operation, or I’m a production organization, … is creating positive all of a sudden [that] your indemnification provisions as agreements take on a a lot larger aspect of the contract,” Crow says. “If you are a vertically integrated operator, there’s seriously no way to safeguard your self, other than to place in location GMP requirements to safeguard your self from the solution liability claim and obtaining brought into some giant class action lawsuits. But these that are in the retail or production [side of the business], these agreements have a lot additional value than what they have had historically.”
Vet Your Provide Chain
Now’s the time, if you haven’t gone via this course of action lately, to get up-close and individual with your provide chain and re-interrogate its trustworthiness and compliance. The shape of legal claims is a matter of debate, but class-action lawsuits have emerged in many regions of the cannabis space, and it aids to determine and address any weak spots in a business’s interactions with third-celebration vendors or in other partnerships.
“First of all, we do not seriously know sufficient to know the sorts of claims that will emerge,” Bodamer says. “I know that the plaintiff’s bar is inventive, but they’re also attentive. And in this context, they’re going to be following the outcomes of ongoing investigations at the state level and at the federal level. And to the extent that [those] investigations reveal particular sources, and if these particular sources have been supplying solution to person providers, if that provide chain is in any way illegal, … I consider the ease with which the plaintiff’s bar could bring claims would go up drastically.”
Having out in front of the national news narrative with public statements on social media is 1 point displaying proof of Superior Manufacturing Principles or other requirements and certifications will make a clear statement to the customer base—and to public officials and private attorneys interested in parsing businesses’ tangential roles to a story with an expansive attain.
“You’re going to see scrutiny and the emergence of very good actors versus undesirable actors from a provide chain standpoint,” he says. “It’s incumbent on very good actors to point out their greatest practices, but it is also incumbent on folks to not be undesirable actors.”
…This Involves Licensing Arrangements
“Who could potentially get caught up in [litigation], I consider, is a very good query as nicely,” Crow says, “because the way that lots of of the providers are [set up], and this is not news, is that you are expanding to licensing arrangements. You can see your brand eviscerated if it is caught up in a dirty-variety pen or delivery method, or it gets [linked to] an edible that [causes] a undesirable outcome or an adverse consequence.”
Any connection to other brands or other providers is a hyperlink worth examining, even in additional relaxed instances that are not burdened with a national news story and a increasing count of sicknesses and deaths. Licensing agreements are, of course, integrated in this.
“You’re seriously placing a lot of trust in production providers that they are performing issues adequately and appropriately in not violating state guidelines or adhering to the greatest doable regular that they could adhere to,” Crow says.
Bodamer adds an vital comply with-up, reminding cannabis firms to be conscious often of the federal government’s stance on cannabis: “That non-compliance across state lines also removes what would have been 1 of the … de facto protections from the federal prosecutorial standpoint, which is that if you are keep compliant, there’s much less of an interest in federal prosecution.”
Supply: A single